TARGET Acute Lymphoblastic Leukemia (ALL)
Program Description
GDC studies: TARGET-ALL-P1, TARGET-ALL-P2, and TARGET-ALL-P3
The TARGET Acute Lymphoblastic Leukemia projects uses comprehensive molecular characterization to determine the genetic changes that drive the initiation and progression of hard-to-treat childhood cancers. Acute lymphoblastic leukemia (ALL) is a cancer of white blood cells, the cells in the body that normally fight infection.